Actis invests in Indian pharma company - Reuters

Private equity firm Actis has invested $48 million in Indian pharmaceuticals company Symbiotec Pharmalab for a significant stake, writes Reuters. Symbiotec is a specialist producer of steroid-hormone active pharmaceutical ingredients and has over 200 customers, including large multinationals as well as generic pharmaceutical companies.

DealsNorth AmericaUSBriefs